What is KYMR stock price today?

Visit our real-time dashboard for the current KYMR stock price and live market data.

Is KYMR stock going up or down today?

KYMR stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy KYMR stock now?

The decision to buy KYMR depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is KYMR a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for KYMR based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is KYMR stock overvalued or undervalued?

Use our DCF valuation calculator to determine if KYMR is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is KYMR's P/E ratio?

P/E ratio data for KYMR will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is KYMR's market cap?

KYMR (Kymera Therapeutics Inc) has a market capitalization of $7.39 billion, making it a small-cap stock.

What is KYMR's price to book ratio?

KYMR trades at a price-to-book (P/B) ratio of 4.80, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does KYMR pay dividends?

KYMR does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is KYMR's dividend yield?

KYMR does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is KYMR stock a good long-term investment?

KYMR's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is KYMR's revenue growth rate?

Revenue growth data for KYMR is available on our dashboard with detailed financial statement analysis.

Profitability metrics for KYMR are available on our dashboard with complete income statement analysis.

What are the risks of investing in KYMR?

Key risks for KYMR include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does KYMR compare to its competitors?

Compare KYMR to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize KYMR's performance and positioning.

What is KYMR's stock price target for 2026?

Visit our prediction page for AI-powered price targets for KYMR with bull, base, and bear case scenarios.

What do analysts say about KYMR?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for KYMR. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is KYMR's next earnings report?

KYMR reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

KYMR - Kymera Therapeutics Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Kymera Therapeutics Inc

Kymera Therapeutics Inc (KYMR) common stock

Price Chart

Loading chart...

KYMR Key Statistics

Market Cap

$7.39B

P/B Ratio

4.80

How KYMR Compares to Peers

KYMR is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
KYMR(This stock)	$7.39B	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 17, 2026 at 4:54 PM EDT

Ready to invest in KYMR?

Commission-free trading available. Affiliate links.

KYMR Lician Score

13% confidence

4.0/10

Neutral

KYMR has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates KYMRacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

KYMR Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for KYMR

Dashboard

Enter a ticker to analyze